Cerecor Inc (CERC) Fundamental Analysis & Valuation
NASDAQ:CERC
Current stock price
2.93
-0.05 (-1.68%)
At close:
2.9468
+0.02 (+0.57%)
After Hours:
This CERC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CERC Profitability Analysis
1.1 Basic Checks
- In the past year CERC has reported negative net income.
1.2 Ratios
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -119.98% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | -1201.64% | ||
| PM (TTM) | -1194.83% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. CERC Health Analysis
2.1 Basic Checks
- CERC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- Based on the Altman-Z score of -4.37, we must say that CERC is in the distress zone and has some risk of bankruptcy.
- A Debt/Equity ratio of 0.79 indicates that CERC is somewhat dependend on debt financing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.79 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -4.37 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 2.19 indicates that CERC has no problem at all paying its short term obligations.
- A Quick Ratio of 2.18 indicates that CERC has no problem at all paying its short term obligations.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.19 | ||
| Quick Ratio | 2.18 |
3. CERC Growth Analysis
3.1 Past
- CERC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -49.12%.
- The Revenue has decreased by -6.39% in the past year.
- The Revenue for CERC have been decreasing by -37.78% on average. This is quite bad
EPS 1Y (TTM)-49.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.26%
Revenue 1Y (TTM)-6.39%
Revenue growth 3Y-37.78%
Revenue growth 5YN/A
Sales Q2Q%150.78%
3.2 Future
- CERC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.94% yearly.
- Based on estimates for the next years, CERC will show a very strong growth in Revenue. The Revenue will grow by 120.79% on average per year.
EPS Next Y4.09%
EPS Next 2Y11.13%
EPS Next 3Y16.75%
EPS Next 5Y7.94%
Revenue Next Year-12.27%
Revenue Next 2Y17.22%
Revenue Next 3Y104.26%
Revenue Next 5Y120.79%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. CERC Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for CERC. In the last year negative earnings were reported.
- Also next year CERC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | -3.42 |
4.3 Compensation for Growth
- CERC's earnings are expected to grow with 16.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.13%
EPS Next 3Y16.75%
5. CERC Dividend Analysis
5.1 Amount
- No dividends for CERC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CERC Fundamentals: All Metrics, Ratios and Statistics
2.93
-0.05 (-1.68%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.01%
Inst Owner Change0%
Ins Owners3.95%
Ins Owner Change0%
Market Cap281.31M
Revenue(TTM)6.43M
Net Income(TTM)-76.89M
Analysts100
Price Target6.63 (126.28%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 43.72 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 13.03 | ||
| P/tB | N/A | ||
| EV/EBITDA | -3.42 |
EPS(TTM)-0.85
EYN/A
EPS(NY)-0.67
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.07
BVpS0.22
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -119.98% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | -1201.64% | ||
| PM (TTM) | -1194.83% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.79 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.19 | ||
| Quick Ratio | 2.18 | ||
| Altman-Z | -4.37 |
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.26%
EPS Next Y4.09%
EPS Next 2Y11.13%
EPS Next 3Y16.75%
EPS Next 5Y7.94%
Revenue 1Y (TTM)-6.39%
Revenue growth 3Y-37.78%
Revenue growth 5YN/A
Sales Q2Q%150.78%
Revenue Next Year-12.27%
Revenue Next 2Y17.22%
Revenue Next 3Y104.26%
Revenue Next 5Y120.79%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A
Cerecor Inc / CERC Fundamental Analysis FAQ
What is the ChartMill fundamental rating of Cerecor Inc (CERC) stock?
ChartMill assigns a fundamental rating of 1 / 10 to CERC.
What is the valuation status of Cerecor Inc (CERC) stock?
ChartMill assigns a valuation rating of 0 / 10 to Cerecor Inc (CERC). This can be considered as Overvalued.
Can you provide the profitability details for Cerecor Inc?
Cerecor Inc (CERC) has a profitability rating of 0 / 10.
What is the earnings growth outlook for Cerecor Inc?
The Earnings per Share (EPS) of Cerecor Inc (CERC) is expected to grow by 4.09% in the next year.